文献速递消化内镜消化道肿瘤与早癌

大型社区医疗系统中腺瘤检出「一发现即停止」现象的发生率

Prevalence of "one and done" phenomenon in adenoma detection within a large community-based healthcare system.
PubMed 文献 · Gastrointest Endosc · 2024-10-29

该回顾性队列研究分析了2015至2020年间Sutter Health-Palo Alto Medical Foundation的32名内镜医师完成的89,587例筛查结肠镜检查,总体腺瘤检出率(ADR)为45.4%。单发腺瘤检出率(ADR1)与多发腺瘤检出率(ADR2+)呈正相关(Pearson r=0.701,P<.001),仅4/32名内镜医师符合「一发现即停止」类别,提示该现象在临床实践中并不常见,ADR仍可作为多发腺瘤检出的良好替代指标。

要点

  • 总体ADR为45.4%,ADR1与ADR2+中位数分别为23.95%和21.29%。
  • ADR1与ADR2+呈正相关(Pearson r=0.701,P<.001)。
  • 仅4/32名内镜医师符合「一发现即停止」类别。

核心结论

  • ADR1与ADR2+相关,尽管存在担忧,「一发现即停止」现象在临床实践中并不常见,ADR仍是多发腺瘤检出的良好替代指标。

研究设计与样本

  • 回顾性队列研究,使用2015至2020年间Sutter Health-Palo Alto Medical Foundation的32名内镜医师完成的89,587例筛查结肠镜检查数据。

主要发现

  • 总体ADR为45.4%。
  • ADR1与ADR2+中位数分别为23.95%和21.29%。
  • ADR1与ADR2+呈正相关(Pearson相关系数r=0.701,P<.001)。
  • 仅4/32名内镜医师符合「一发现即停止」类别。

关键数值与推荐

  • 基于ADR1和ADR2+中位数将内镜医师分为4类:低ADR1高ADR2+(「全或无」)、低ADR1低ADR2+(「无即止」)、高ADR1高ADR2+(「全即止」)、高ADR1低ADR2+(「一发现即停止」)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Adenoma detection rate (ADR) is a key quality metric in colonoscopy, reflecting the ability to detect adenomas. However, concerns remain regarding the robustness of ADR as a benchmark. In particular, the "one and done" phenomenon may exist in which physicians are less motivated to find additional adenomas after discovery of the first adenoma. To investigate this topic further, our goal was to understand the relationship between single and multiple adenoma detection. METHODS: A retrospective cohort study was conducted by using data from 89,587 screening colonoscopies performed by 32 endoscopists within the Sutter Health-Palo Alto Medical Foundation between 2015 and 2020. ADR, single adenoma detection rate (ADR1), and multiple adenoma detection rate (ADR2+) were analyzed by using multivariate logistic regression and linear regression models. Endoscopists were then fit into 4 categories based on median ADR1 and ADR2+ (low ADR1, high ADR2+ ["all or none"], low ADR1, low ADR2+ ["none and done"], high ADR1, high ADR2+ ["all and done"], or high ADR1, low ADR2+ ["one and done"]). RESULTS: The overall ADR was 45.4%. ADR, ADR1, and ADR2+ were significantly associated with similar factors, including older age, male sex, higher body mass index, smoking status, high-risk colonoscopies, Medicare insured, use of mucosal assist devices, longer withdrawal times, adequate preparation, and procedures performed by high-volume, female endoscopists with a longer duration in practice. The median ADR1 and ADR2+ were 23.95% and 21.29%, respectively. ADR1 and ADR2+ were positively correlated (Pearson correlation coefficient [r], .701; P < .001). Only 4 of 32 endoscopists fit our "one and done" category. CONCLUSIONS: These findings suggest that ADR1 correlates with ADR2+. Despite concerns, the "one and done" phenomenon is not commonly seen in clinical practice. ADR remains a good surrogate marker for multiple adenoma detection.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Huang ES, Huang Q, Kenkare P, et al. Prevalence of "one and done" phenomenon in adenoma detection within a large community-based healthcare system. Gastrointest Endosc. 2024. PMID: 39481577. doi:10.1016/j.gie.2024.10.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。